Abstract
Major contributors in the control of food intake include behavioral response to the environment, hedonic behavior, and metabolism: nutrient sensors, neuropeptide hormones, and peripheral hormones. All combined contribute to three primary stimuli to eat: hunger, reward, and stress. The brain plays a critical role in relaying information about the neuroendocrine and endocrine system regulating the energy network. The mechanisms for controlling food intake require interaction among three major components: the gut, brain, and adipose tissue. The parasympathetic, sympathetic, and other systems are also needed for communication between the brain satiety center, gut, and adipose tissue. These neuronal circuits include many neuropeptide hormones and peptide hormones coming from the periphery, all acting in concert in the regulation of food intake and energy homeostasis. This chapter describes mostly brain peptide hormones and some coming from the periphery. The interested reader could find a full description of all peptide hormones involved in energy balance regulation in a recent review by Crespo et al. (2014). Although regulation of energy homeostasis engages several brain regions including the brainstem, cortex, amygdala, and the limbic system, it is the hypothalamus that is responsible for integrating neuronal and humoral signals in the control feeding behavior. In response to sensory and social stimulation including visual, smell, taste, stress, reward, culture, and exercise, a feeding center in the hypothalamus initiates food uptake that is then terminated by a satiety center. Both the gastrointestinal tract and the white fat cells are responsible for releasing hormone signals that are integrated with the hypothalamus and nucleus of the solitary tract (NTS) to control feeding neural circuits. In spite of the sophistication of these interconnected systems, which are tightly regulated to control energy demand with energy expenditure, the recent sizeable increase in the prevalence of obesity seen in modern urban societies represents a deviation of this evolutionary control of weight homeostasis. Among the major contributors to this disarrangement of the feeding control system are highly palatable and relatively cheap foods ubiquitously available and unfamiliar to our genetic repertoire. The massive reduction in physical activity also contributed to this condition. These current life factors combined with the evolutionary genetic predisposition are the leading causes of the common obesity. This chapter describes the role of neuropeptide and some essential peripheral hormones interacting in the hypothalamus toward controlling feeding behavior. The role of hypothalamic nutrient sensors, important in metabolic sensing, is discussed in Chap. 7.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguilera, G., Subburaju, S., Young, S., & Chen, J. (2008). The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress. Progress in Brain Research, 29–39. https://doi.org/10.1016/S0079-6123(08)00403-2.
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996). Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250–252.
Air, E. L., Benoit, S. C., Blake Smith, K. A., Clegg, D. J., & Woods, S. C. (2002). Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacology, Biochemistry, and Behavior, 72, 423–429.
Ao, Y., Go, V. L., Toy, N., Li, T., Wang, Y., Song, M. K., Reeve, J. R., Jr., Liu, Y., & Yang, H. (2006). Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion. Endocrinology, 6004–6010. https://doi.org/10.1210/en.2006-0820.
Bagdade, J. D., Bierman, E. L., & Porte, D., Jr. (1967). The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. The Journal of Clinical Ivestigation, 1549–1557. https://doi.org/10.1172/JCI105646.
Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., McGovern, R. A., Chua, S. C., Jr., Elmquist, J. K., & Lowell, B. B. (2004). Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron, 42, 983–991.
Barsh, G. S., & Schwartz, M. W. (2002). Genetic approaches to studying energy balance: Perception and integration. Nature Reviews Genetics, 3(8), 589–600.
Bates, S. H., Stearns, W. H., Dundon, T. A., Schubert, M., Tso, A. W., Wang, Y., Banks, A. S., Lavery, H. J., Haq, A. K., Maratos-Flier, E., Neel, B. G., Schwartz, M. W., & Myers, M. G., Jr. (2003). STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature, 421, 856–859.
Baumann, H., Morella, K. K., White, D. W., Dembski, M., Bailon, P. S., Kim, H., Lai, C.-F., & Tartaglia, L. A. (1996). The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proceedings of the National Academy of Sciences, 93, 8374–8378.
Baura, G. D., Foster, D. M., Porte, D., Jr., Kahn, S. E., Bergman, R. N., Cobelli, C., & Schwartz, M. W. (1993). Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. The Journal of Clinical Ivestigation, 92, 1824–1830. https://doi.org/10.1172/JCI116773.
Beck, B., Jhanwar-Uniyal, M., Burlet, A., Chapleur-Chateau, M., Leibowitz, S. F., & Burlet, C. (1990). Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Research, 528, 245–249.
Benoit, S. C., Air, E. L., Coolen, L. M., Strauss, R., Jackman, A., Clegg, D. J., Seeley, R. J., & Woods, S. C. (2002). The catabolic action of insulin in the brain is mediated by melanocortins. Journal of Neuroscience, 22, 9048–9052.
Berthoud, H. R. (2011). Metabolic and hedonic drives in the neural control of appetite: Who is the boss? Current Opinion in Neurobiology, 888–896. https://doi.org/10.1016/j.conb.2011.09.004.
Bi, S., Ladenheim, E. E., Schwartz, G. J., & Moran, T. H. (2001). A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 281, R254–R260.
Biebermann, H., Castaneda, T. R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschop, M. H., Gruters, A., & Krude, H. (2006). A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metabolism, 141–146. https://doi.org/10.1016/j.cmet.2006.01.007.
Bingham, N. C., Anderson, K. K., Reuter, A. L., Stallings, N. R., & Parker, K. L. (2008). Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology, 2138–2148. https://doi.org/10.1210/en.2007-1200.
Bjørbæk, C., Uotani, S., da Silva, B., & Flier, J. S. (1997). Divergent signaling capacities of the long and short isoforms of the leptin receptor. Journal of Biological Chemistry, 272, 32686–32695.
Broadwell, R. D., & Brightman, M. W. (1976). Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. The Journal of Comparative Neurology, 257–283. https://doi.org/10.1002/cne.901660302.
Broberger, C., Johansen, J., Johansson, C., Schalling, M., & Hokfelt, T. (1998). The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proceedings of the National Academy of Sciences, 95, 15043–15048.
Bronstein, D. M., Schafer, M. K., Watson, S. J., & Akil, H. (1992). Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: Detection of POMC mRNA. Brain Research, 587, 269–275.
Bumaschny, V. F., Yamashita, M., Casas-Cordero, R., Otero-Corchon, V., de Souza, F. S., Rubinstein, M., & Low, M. J. (2012). Obesity-programmed mice are rescued by early genetic intervention. The Journal of Clinical Investigation, 4203–4212. https://doi.org/10.1172/JCI62543.
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995). Recombinant mouse OB protein: Evidence for peripheral signal linking adiposity and central neural networks. Science, 269, 546–549.
Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W. S., Sugimoto, K., Cetrulo, C. L., & Theoharides, T. C. (2005). Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. The Journal of Immunology, 174, 7665–7675.
Cason, A. M., Smith, R. J., Tahsili-Fahadan, P., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2010). Role of orexin/hypocretin in reward-seeking and addiction: Implications for obesity. Physiology & Behavior, 419–428. https://doi.org/10.1016/j.physbeh.2010.03.009.
Chao, P. T., Yang, L., Aja, S., Moran, T. H., & Bi, S. (2011). Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell Metabolism, 573–583. https://doi.org/10.1016/j.cmet.2011.02.019.
Chen, H., Chatlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., Moore, K. J., Breitbart, R. E., Duyk, G. M., Tepper, R. I., & Morgenstern, J. P. (1996). Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell, 84, 491–495.
Cheung, C. C., Clifton, D. K., & Steiner, R. A. (1997). Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology, 138, 4489–4492.
Cheung, C. C., Kurrasch, D. M., Liang, J. K., & Ingraham, H. A. (2013). Genetic labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a separate non-SF-1 neuronal cluster in the ventrolateral VMH. The Journal of Comparative Neurology, 1268–1288. https://doi.org/10.1002/cne.23226.
Chieffi, S., Carotenuto, M., Monda, V., Valenzano, A., Villano, I., Precenzano, F., Tafuri, D., Salerno, M., Filippi, N., Nuccio, F., Ruberto, M., De Luca, V., Cipolloni, L., Cibelli, G., Mollica, M. P., Iacono, D., Nigro, E., Monda, M., Messina, G., & Messina, A. (2017). Orexin system: The key for a healthy life. Frontiers in Physiology, 357. https://doi.org/10.3389/fphys.2017.00357.
Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. The New England Journal of Medicine, 1351–1362. https://doi.org/10.1056/NEJM199505183322008.
Ciriello, J., McMurray, J. C., Babic, T., & de Oliveira, C. V. (2003). Collateral axonal projections from hypothalamic hypocretin neurons to cardiovascular sites in nucleus ambiguus and nucleus tractus solitarius. Brain Research, 991, 133–141.
Clark, J. T., Kalra, P. S., Crowley, W. R., & Kalra, S. P. (1984). Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology, 427–429. https://doi.org/10.1210/endo-115-1-427.
Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J. M., Basdevant, A., Bougneres, P., Lebouc, Y., Froguel, P., & Guy-Grand, B. (1998). A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature, 392, 398–401.
Coleman, D. L. (1982). Thermogenesis in diabetes-obesity syndromes in mutant mice. Diabetologia, 22, 205–211.
Coll, A. P., Farooqi, I. S., Challis, B. G., Yeo, G. S., & O'Rahilly, S. (2004). Proopiomelanocortin and energy balance: Insights from human and murine genetics. The Journal of Clinical Endocrinology & Metabolism, 89, 2557–2562.
Commins, S. P., Watson, P. M., Padgett, M. A., Dudley, A., Argyropoulos, G., & Gettys, T. W. (1999). Induction of uncoupling protein expression in brown and white adipose tissue by leptin. Endocrinology, 140, 292–300.
Commins, S. P., Watson, P. M., Levin, N., Beiler, R. J., & Gettys, T. W. (2000). Central leptin regulates the UCP1 and ob genes in brown and white adipose tissue via different beta-adrenoceptor subtypes. Journal of Biological Chemistry, 33059–33067. https://doi.org/10.1074/jbc.M006328200. M006328200 [pii].
Corander, M. P., Rimmington, D., Challis, B. G., O'Rahilly, S., & Coll, A. P. (2011). Loss of agouti-related peptide does not significantly impact the phenotype of murine POMC deficiency. Endocrinology, 1819–1828. https://doi.org/10.1210/en.2010-1450.
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature, 411, 480–484.
Cyr, N. E., Toorie, A. M., Steger, J. S., Sochat, M. M., Hyner, S., Perello, M., Stuart, R., & Nillni, E. A. (2013). Mechanisms by which the orexigen NPY regulates anorexigenic alpha-MSH and TRH. American Journal of Physiology-Endocrinology and Metabolism, 67, E640–E650. https://doi.org/10.1152/ajpendo.00448.2012.
da Silva, A. A., Kuo, J. J., & Hall, J. E. (2004). Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension, 43, 1312–1317.
Davis, A. M., Seney, M. L., Stallings, N. R., Zhao, L., Parker, K. L., & Tobet, S. A. (2004). Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamus. Journal of Neurobiology, 424–436. https://doi.org/10.1002/neu.20030.
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L., Gautvik, V. T., Bartlett, F. S., 2nd, Frankel, W. N., van den Pol, A. N., Bloom, F. E., Gautvik, K. M., & Sutcliffe, J. G. (1998). The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences, 95, 322–327.
DiLeone, R. J., Taylor, J. R., & Picciotto, M. R. (2012). The drive to eat: Comparisons and distinctions between mechanisms of food reward and drug addiction. Nature Neuroscience, 1330–1335. https://doi.org/10.1038/nn.3202.
Druce, M. R., Small, C. J., & Bloom, S. R. (2004). Minireview: Gut peptides regulating satiety. Endocrinology, 2660–2665. https://doi.org/10.1210/en.2004-0089.
Dube, M. G., Kalra, S. P., & Kalra, P. S. (1999). Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action. Brain Research, 842, 473–477.
Egawa, M., Yoshimatsu, H., & Bray, G. A. (1991). Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 260, R328–R334.
Elias, C. F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R. S., Bjorbaek, C., Flier, J. S., Saper, C. B., & Elmquist, J. K. (1999). Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron, 23, 775–786.
Ellacott, K. L., & Cone, R. D. (2006). The role of the central melanocortin system in the regulation of food intake and energy homeostasis: Lessons from mouse models. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 361, 1265–1274.
Elmquist, J. K., Bjorbaek, C., Ahima, R. S., Flier, J. S., & Saper, C. B. (1998). Distributions of leptin receptor mRNA isoforms in the rat brain. Journal of Comparative Neurology, 395, 535–547.
Elmquist, J. K., Elias, C. F., & Saper, C. B. (1999). From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron, 221–232. https://doi.org/S0896-6273(00)81084-3 [pii].
Erickson, J. C., Clegg, K. E., & Palmiter, R. D. (1996a). Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 415–421. https://doi.org/10.1038/381415a0.
Erickson, J. C., Hollopeter, G., & Palmiter, R. D. (1996b). Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science, 274, 1704–1707.
Ernst, M. B., Wunderlich, C. M., Hess, S., Paehler, M., Mesaros, A., Koralov, S. B., Kleinridders, A., Husch, A., Munzberg, H., Hampel, B., Alber, J., Kloppenburg, P., Bruning, J. C., & Wunderlich, F. T. (2009). Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. Journal of Neuroscience, 11582–11593. 29/37/11582 [pii]. https://doi.org/10.1523/JNEUROSCI.5712-08.2009.
Everitt, B. J., Hokfelt, T., Terenius, L., Tatemoto, T., Mutt, V., & Goldstein, M. (1984). Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience, 11, 443.
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997). Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature, 385, 165–168.
Fekete, C., Legradi, G., Mihaly, E., Huang, Q. H., Tatro, J. B., Rand, W. M., Emerson, C. H., & Lechan, R. M. (2000a). alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. Journal of Neuroscience, 20, 1550–1558.
Fekete, C., Mihaly, E., Luo, L. G., Kelly, J., Clausen, J. T., Mao, Q., Rand, W. M., Moss, L. G., Kuhar, M., Emerson, C. H., Jackson, I. M., & Lechan, R. M. (2000b). Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting. Journal of Neuroscience, 20, 9224–9234.
Fekete, C., Kelly, J., Mihaly, E., Sarkar, S., Rand, W. M., Legradi, G., Emerson, C. H., & Lechan, R. M. (2001). Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology, 142, 2606–2613.
Fekete, C., Sarkar, S., Rand, W. M., Harney, J. W., Emerson, C. H., Bianco, A. C., Beck-Sickinger, A., & Lechan, R. M. (2002). Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Endocrinology, 143, 4513–4519.
Flier, J. S. (1998). Clinical review 94: What’s in a name? In search of leptin’s physiologic role. The Journal of Clinical Endocrinology and Metabolism, 83, 1407–1413.
Flier, J. S., & Maratos-Flier, E. (1998). Obesity and the hypothalamus: Novel peptides for new pathways. Cell, 92, 437–440.
Fliers, E., Noppen, N. W., Wiersinga, W. M., Visser, T. J., & Swaab, D. F. (1994). Distribution of thyrotropin-releasing hormone (TRH)-containing cells and fibers in the human hypothalamus. Journal of Comparative Neurology, 350, 311–323.
Gehlert, D. R., Chronwall, B. M., Schafer, M. P., & O'Donohue, T. L. (1987). Localization of neuropeptide Y messenger ribonucleic acid in rat and mouse brain by in situ hybridization. Synapse, 25–31. https://doi.org/10.1002/syn.890010106.
Ghilardi, N., Ziegler, S., Wiestner, A., Stoffel, R., Heim, M. H., & Skoda, R. C. (1996). Defective STAT signaling by the leptin receptor in diabetic mice. Proceedings of the National Academy of Sciences, 93, 6231–6235.
Gil, K., Bugajski, A., & Thor, P. (2011). Electrical vagus nerve stimulation decreases food consumption and weight gain in rats fed a high-fat diet. Journal of Physiology and Pharmacology, 62, 637–646.
Graham, M., Shutter, J. R., Sarmiento, U., Sarosi, I., & Stark, K. L. (1997). Overexpression of Agrp leads to obesity in transgenic mice. Nature Genetics, 273–274. https://doi.org/10.1038/ng1197-273.
Greenman, Y., Kuperman, Y., Drori, Y., Asa, S. L., Navon, I., Forkosh, O., Gil, S., Stern, N., & Chen, A. (2013). Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior. Molecular Endocrinology, 1091–1102. https://doi.org/10.1210/me.2012-1344.
Gropp, E., Shanabrough, M., E Borok, A. W. X., Janoschek, R., Buch, T., Plum, L., Balthasar, N., Hampel, B., Waisman, A., Barsh, G. S., Horvath, T. L., & Bruning, J. C. (2005). Agouti-related peptide-expressing neurons are mandatory for feeding. Nature Neuroscience, 1289–1291. https://doi.org/10.1038/nn1548.
Guan, X. M., Yu, H., Trumbauer, M., Frazier, E., Van der Ploeg, L. H., & Chen, H. (1998). Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice. Neuroreport, 9, 3415–3419.
Guldenaar, S. E., Veldkamp, B., Bakker, O., Wiersinga, W. M., Swaab, D. F., & Fliers, E. (1996). Thyrotropin-releasing hormone gene expression in the human hypothalamus. Brain Research, 743, 93–101.
Guo, L., Munzberg, H., Stuart, R. C., Nillni, E. A., & Bjorbaek, C. (2004). N-acetylation of hypothalamic alpha-melanocyte-stimulating hormone and regulation by leptin. Proceedings of the National Academy of Sciences of the United States of America, 101, 11797–11802.
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science, 269, 543–546.
Haskell-Luevano, C., & Monck, E. K. (2001). Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regulatory Peptides, 99, 1–7.
Havrankova, J., Roth, J., & Brownstein, M. (1978a). Insulin receptors are widely distributed in the central nervous system of the rat. Nature, 272, 827–829.
Havrankova, J., Schmechel, D., Roth, J., & Brownstein, M. (1978b). Identification of insulin in rat brain. Proceedings of the National Academy of Sciences, 75, 5737–5741.
Haynes, W. G., Morgan, D. A., Djalali, A., Sivitz, W. I., & Mark, A. L. (1999). Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension, 33, 542–547.
Hentges, S. T., Nishiyama, M., Overstreet, L. S., Stenzel-Poore, M., Williams, J. T., & Low, M. J. (2004). GABA release from proopiomelanocortin neurons. Journal of Neuroscience, 1578–1583. https://doi.org/10.1523/JNEUROSCI.3952-03.2004.
Hu, J., Ludwig, T. E., Salli, U., Stormshak, F., & Mirando, M. A. (2001). Autocrine/paracrine action of oxytocin in pig endometrium. Biology of Reproduction, 64, 1682–1688.
Huo, L., Munzberg, H., Nillni, E. A., & Bjorbaek, C. (2004). Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene expression by leptin. Endocrinology, 145, 2516–2523.
Ihle, J. N. (1995). Cytokine receptor signalling. Nature, 377, 591–594.
Ishikawa, K., Taniguchi, Y., Inoue, K., Kurosumi, K., & Suzuki, M. (1988). Immunocytochemical delineation of thyrotropic area: Origin of thyrotropin-releasing hormone in the median eminence. Neuroendocrinology, 47, 384.
Joseph, S. A., & Michael, G. J. (1988). Efferent ACTH-IR opiocortin projections from nucleus tractus solitarius: A hypothalamic deafferentation study. Peptides, 9, 193–201.
Kalra, S. P. (1997). Appetite and body weight regulation: is it all in the brain. Neuron, 19, 227–230.
Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P., & Kalra, P. S. (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences, 88, 10931–10935.
Kielar, D., Clark, J. S., Ciechanowicz, A., Kurzawski, G., Sulikowski, T., & Naruszewicz, M. (1998). Leptin receptor isoforms expressed in human adipose tissue. Metabolism, 47, 844–847.
Kim, M. S., Small, C. J., Stanley, S. A., Morgan, D. G., Seal, L. J., Kong, W. M., Edwards, C. M., Abusnana, S., Sunter, D., Ghatei, M. A., & Bloom, S. R. (2000a). The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. The Journal of Clinical Investigation, 105, 1005–1011.
Kim, M. S., Rossi, M., Abusnana, S., Sunter, D., Morgan, D. G., Small, C. J., Edwards, C. M., Heath, M. M., Stanley, S. A., Seal, L. J., Bhatti, J. R., Smith, D. M., Ghatei, M. A., & Bloom, S. R. (2000b). Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes, 49, 177–182.
Kim, K. W., Zhao, L., Donato, J., Jr., Kohno, D., Xu, Y., Elias, C. F., Lee, C., Parker, K. L., & Elmquist, J. K. (2011). Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus. Proceedings of the National Academy of Sciences of the United States of America, 10673–10678. https://doi.org/10.1073/pnas.1102364108.
Kim, J. D., Leyva, S., & Diano, S. (2014). Hormonal regulation of the hypothalamic melanocortin system. Frontiers in Physiology, 480. https://doi.org/10.3389/fphys.2014.00480.
Kishi, T., Aschkenasi, C. J., Lee, C. E., Mountjoy, K. G., Saper, C. B., & Elmquist, J. K. (2003). Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. Journal of Comparative Neurology, 457, 213–235.
Kitamura, T., Feng, Y., Kitamura, Y. I., Chua, S. C., Jr., Xu, A. W., Barsh, G. S., Rossetti, L., & Accili, D. (2006). Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nature Medicine, 12, 534–540.
Kong, X., Yu, J., Bi, J., Qi, H., W Di, L. W., Wang, L., Zha, J., Lv, S., Zhang, F., Y Li, F. H., Liu, F., Zhou, H., Liu, J., & Ding, G. (2014). Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue. Diabetes. https://doi.org/10.2337/db14-0395.
Konner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., X Ma, C. X., Enriori, P., Hampel, B., Barsh, G. S., Kahn, C. R., Cowley, M. A., Ashcroft, F. M., & Bruning, J. C. (2007). Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metabolism, 438–449. https://doi.org/10.1016/j.cmet.2007.05.004.
Korosi, A., & Baram, T. Z. (2008). The central corticotropin releasing factor system during development and adulthood. European Journal of Pharmacology, 204–214. https://doi.org/10.1016/j.ejphar.2007.11.066.
Kovacs, K. J. (2013). CRH: The link between hormonal-, metabolic- and behavioral responses to stress. Journal of Chemical Neuroanatomy, 25–33. https://doi.org/10.1016/j.jchemneu.2013.05.003.
Krude, H., & Gruters, A. (2000). Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome. Trends in Endocrinology and Metabolism: TEM, 11, 15–22.
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., & Gruters, A. (1998). Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genetics, 155–157. https://doi.org/10.1038/509.
Laryea, G., Schutz, G., & Muglia, L. J. (2013). Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity. Molecular Endocrinology, 1655–1665. https://doi.org/10.1210/me.2013-1187.
Lee, M., & Wardlaw, S. L. (2007). The central melanocortin system and the regulation of energy balance. Frontiers in Bioscience, 12, 3994–4010.
Lee, G. H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature, 379, 632–635.
Lee, Y. S., Challis, B. G., Thompson, D. A., Yeo, G. S., Keogh, J. M., Madonna, M. E., Wraight, V., Sims, M., Vatin, V., Meyre, D., Shield, J., Burren, C., Ibrahim, Z., Cheetham, T., Swift, P., Blackwood, A., Hung, C. C., Wareham, N. J., Froguel, P., Millhauser, G. L., O'Rahilly, S., & Farooqi, I. S. (2006). A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metabolism, 135–140. https://doi.org/10.1016/j.cmet.2006.01.006.
Lee, M., Kim, A., Chua, S. C., Jr., Obici, S., & Wardlaw, S. L. (2007). Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. American Journal of Physiology-Endocrinology and Metabolism, E121–E131. https://doi.org/10.1152/ajpendo.00555.2006.
Lopez, M., Varela, L., Vazquez, M. J., Rodriguez-Cuenca, S., Gonzalez, C. R., Velagapudi, V. R., Morgan, D. A., Schoenmakers, E., Agassandian, K., Lage, R., Martinez de Morentin, P. B., Tovar, S., Nogueiras, R., Carling, D., Lelliott, C., Gallego, R., Oresic, M., Chatterjee, K., Saha, A. K., Rahmouni, K., Dieguez, C., & Vidal-Puig, A. (2010). Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine, 1001–1008. https://doi.org/10.1038/nm.2207.
Lovejoy, D. A., Chang, B. S., Lovejoy, N. R., & del Castillo, J. (2014). Molecular evolution of GPCRs: CRH/CRH receptors. Journal of Molecular Endocrinology, T43–T60. https://doi.org/10.1530/JME-13-0238.
Luiten, P. G. M., Horst, G. Z., Karst, H., & Steffans, A. B. (1985). The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Research, 329, 374–378.
Marks, J. L., Porte, D., Jr., Stahl, W. L., & Baskin, D. G. (1990). Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology, 3234–3236. https://doi.org/10.1210/endo-127-6-3234.
Marsh, D. J., Weingarth, D. T., Novi, D. E., Chen, H. Y., Trumbauer, M. E., Chen, A. S., Guan, X. M., Jiang, M. M., Feng, Y., Camacho, R. E., Shen, Z., EG Frazier, H. Y., Metzger, J. M., Kuca, S. J., Shearman, L. P., Gopal-Truter, S., MacNeil, D. J., Strack, A. M., MacIntyre, D. E., Van der Ploeg, L. H., & Qian, S. (2002). Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proceedings of the National Academy of Sciences of the United States of America, (5), 3240. https://doi.org/10.1073/pnas.052706899.
Martinez de Morentin, P. B., Whittle, A. J., Ferno, J., Nogueiras, R., Dieguez, C., Vidal-Puig, A., & Lopez, M. (2012). Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes, 807–817. https://doi.org/10.2337/db11-1079.
Mastorakos, G., & Zapanti, E. (2004). The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: The role of corticotropin releasing hormone. Nutritional Neuroscience, 271–280. https://doi.org/10.1080/10284150400020516.
Mathews, S. T., Singh, G. P., Ranalletta, M., Cintron, V. J., Qiang, X., Goustin, A. S., Jen, K. L., Charron, M. J., Jahnen-Dechent, W., & Grunberger, G. (2002). Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes, 51, 2450–2458.
McGowan, M. K., Andrews, K. M., Fenner, D., & Grossman, S. P. (1993). Chronic intrahypothalamic insulin infusion in the rat: Behavioral specificity. Physiology & Behavior, 54, 1031–1034.
Menyhert, J., Wittmann, G., Lechan, R. M., Keller, E., Liposits, Z., & Fekete, C. (2007). Cocaine- and amphetamine-regulated transcript (CART) is colocalized with the orexigenic neuropeptide Y and agouti-related protein and absent from the anorexigenic alpha-melanocyte-stimulating hormone neurons in the infundibular nucleus of the human hypothalamus. Endocrinology, 148, 4276–4281.
Mercer, J. G., Moar, K. M., & Hoggard, N. (1998). Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology, 139, 29–34.
Mercer, A. J., Hentges, S. T., Meshul, C. K., & Low, M. J. (2013). Unraveling the central proopiomelanocortin neural circuits. Frontiers in Neuroscience, 19. https://doi.org/10.3389/fnins.2013.00019.
Mihaly, E., Fekete, C., Tatro, J. B., Liposits, Z., Stopa, E. G., & Lechan, R. M. (2000). Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. The Journal of Clinical Endocrinology & Metabolism, 85, 2596–2603.
Mizuno, T. M., & Mobbs, C. V. (1999). Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology, 140, 814–817.
Mizuno, T. M., Makimura, H., Silverstein, J., Roberts, J. L., Lopingco, T., & Mobbs, C. V. (1999). Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology, 140, 4551–4557.
Mizuno, T. M., Kelley, K. A., Pasinetti, G. M., Roberts, J. L., & Mobbs, C. V. (2003). Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes, 52, 2675–2683.
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., Cheetham, C. H., Earley, A. R., Barnett, A. H., Prins, J. B., & O'Rahilly, S. (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature, 387, 903–908.
Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., & Schwartz, M. W. (2006). Central nervous system control of food intake and body weight. Nature, 443, 289–295.
Munzberg, H., Huo, L., Nillni, E. A., Hollenberg, A. N., & Bjorbaek, C. (2003). Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology, 144, 2121–2131.
Nguyen, A. D., Mitchell, N. F., Lin, S., Macia, L., Yulyaningsih, E., Baldock, P. A., Enriquez, R. F., Zhang, L., Shi, Y. C., Zolotukhin, S., Herzog, H., & Sainsbury, A. (2012). Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice. PLoS ONE, e40191. https://doi.org/10.1371/journal.pone.0040191.
Nillni, E. A. (2010). Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Frontiers in Neuroendocrinology, 134–156 .doi: S0091-3022(10)00002-6 [pii]. https://doi.org/10.1016/j.yfrne.2010.01.001.
Nillni, E. A., & Sevarino, K. A. (1999). The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocrine Reviews, 20, 599–648.
Nillni, E. A., Vaslet, C., Harris, M., Hollenberg, A., Bjorbak, C., & Flier, J. S. (2000). Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. Journal of Biological Chemistry, 275, 36124–36133.
Obici, S. (2009). Molecular targets for obesity therapy in the brain. Endocrinology, 150(6), 2512–2517.
Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science, 278, 135–138.
Palkovits, M., & Eskay, R. L. (1987). Distribution and possible origin of beta-endorphin and ACTH in discrete brainstem nuclei of rats. Neuropeptides, 9, 123–137.
Palkovits, M., Mezey, E., & Eskay, R. L. (1987). Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Research, 436, 323–338.
Palmiter, R. D., Erickson, J. C., Hollopeter, G., Baraban, S. C., & Schwartz, M. W. (1998). Life without neuropeptide Y. Recent Progress in Hormone Research, 53, 163–199.
Parise, E. M., Lilly, N., Kay, K., Dossat, A. M., Seth, R., Overton, J. M., & Williams, D. L. (2011). Evidence for the role of hindbrain orexin-1 receptors in the control of meal size. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, R1692–R1699. https://doi.org/10.1152/ajpregu.00044.2011.
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540–543.
Perello, M., Stuart, R. C., & Nillni, E. A. (2006). The role of intracerebroventricular administration of leptin in the stimulation of prothyrotropin releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology, 147, 3296–3306.
Perello, M., Stuart, R. C., & Nillni, E. A. (2007). Differential Effects of Fasting and Leptin on Pro-Opiomelanocortin Peptides in the Arcuate Nucleus and in the Nucleus of the Solitary Tract. American Journal of Physiology Endocrinology and Metabolism. Am J Physiol Endocrinol Metab. 2007 May;292(5):E1348–57. Epub 2007 Jan 16.
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of Neuroscience, 18, 9996–10015.
Pilcher, W. H., & Joseph, S. A. (1986). Differential sensitivity of hypothalamic and medullary opiocortin and tyrosine hydroxylase neurons to the neurotoxic effects of monosodium glutamate (MSG). Peptides, 7, 783–789.
Poggioli, R., Vergoni, A. V., & Bertolini, A. (1986). ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides, 7, 843–848.
Qian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., X Guan, H. Y., Shen, Z., Feng, Y., Frazier, E., Chen, A., Camacho, R. E., Shearman, L. P., Gopal-Truter, S., MacNeil, D. J., Van der Ploeg, L. H., & Marsh, D. J. (2002). Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Molecular and Cellular Biology, 22, 5027–5035.
Raadsheer, F. C., Sluiter, A. A., Ravid, R., Tilders, F. J., & Swaab, D. F. (1993). Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Research, 615, 50–62.
Resch, J. M., Boisvert, J. P., Hourigan, A. E., Mueller, C. R., Yi, S. S., & Choi, S. (2011). Stimulation of the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating polypeptide induces hypophagia and thermogenesis. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, R1625–R1634. https://doi.org/10.1152/ajpregu.00334.2011.
Rho, J. H., & Swanson, L. W. (1987). Neuroendocrine CRF motoneurons: Intrahypothalamic axon terminals shown with a new retrograde-Lucifer-immuno method. Brain Research, 436, 143–147.
Richard, D., & Baraboi, D. (2004). Circuitries involved in the control of energy homeostasis and the hypothalamic-pituitary-adrenal axis activity. Treatments in Endocrinology, 3, 269–277.
Richard, D., Huang, Q., & Timofeeva, E. (2000). The corticotropin-releasing hormone system in the regulation of energy balance in obesity. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity, 24, S36–S39.
Roeling, T. A., Veening, J. G., Peters, J. P., Vermelis, M. E., & Nieuwenhuys, R. (1993). Efferent connections of the hypothalamic “grooming area” in the rat. Neuroscience, 56, 199–225.
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., & Yanagisawa, M. (1998). Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92, 573–585.
Salem, V., & Bloom, S. R. (2010). Approaches to the pharmacological treatment of obesity. Expert Review of Clinical Pharmacology, 3(1), 73–88.
Sarkar, S., Legradi, G., & Lechan, R. M. (2002). Intracerebroventricular administration of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus. Brain Research, 945, 50–59.
Savontaus, E., Breen, T. L., Kim, A., Yang, L. M., Chua, S. C., Jr., & Wardlaw, S. L. (2004). Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice. Endocrinology, 3881–3891. https://doi.org/10.1210/en.2004-0263.
Sawchenko, P. E., & Pfeiffer, S. W. (1988). Ultrastructural localization of neuropeptide Y and galanin immunoreactivity in the paraventricular nucleus of the hypothalamus in the rat. Brain Research, 474, 231.
Sawchenko, P. E., & Swanson, L. W. (1982). Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. Journal of Comparative Neurology, 260–272. https://doi.org/10.1002/cne.902050306.
Schwartz, M. W., Baskin, D. G., Bukowski, T. R., Kuijper, J. L., Foster, D., Lasser, G., Prunkard, D. E., Porte, D. J., Woods, S. C., Seeley, R. J., & Weigle, D. S. (1996a). Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 45, 531–535.
Schwartz, M. W., Seeley, R. J., Campfield, L. A., Burn, P., & Baskin, D. G. (1996b). Identification of targets of leptin action in rat hypothalamus. The Journal of Clinical Investigation, 98, 1101–1106.
Schwartz, G. J., Whitney, A., Skoglund, C., Castonguay, T. W., & Moran, T. H. (1999). Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. The American Journal of Physiology, 277, R1144–R1151.
Schwartz, M. W., Woods, S. C., Porte, D., Jr., Seeley, R. J., & Baskin, D. G. (2000). Central nervous system control of food intake. Nature, 404, 661–671.
Seeley, R. J., Yagaloff, K. A., Fisher, S. L., Burn, P., Thiele, T. E., van Dijk, G., Baskin, D. G., & Schwartz, M. W. (1997). Melanocortin receptors in leptin effects. Nature, 390, 349.
Segal, J. P., Stallings, N. R., Lee, C. E., Zhao, L., Socci, N., Viale, A., Harris, T. M., Soares, M. B., Childs, G., Elmquist, J. K., Parker, K. L., & Friedman, J. M. (2005). Use of laser-capture microdissection for the identification of marker genes for the ventromedial hypothalamic nucleus. Journal of Neuroscience, 4181–4188. https://doi.org/10.1523/JNEUROSCI.0158-05.2005.
Seimon, R. V., Hostland, N., Silveira, S. L., Gibson, A. A., & Sainsbury, A. (2013). Effects of energy restriction on activity of the hypothalamo-pituitary-adrenal axis in obese humans and rodents: Implications for diet-induced changes in body composition. Hormone Molecular Biology and Clinical Investigation, 71–80. https://doi.org/10.1515/hmbci-2013-0038.
Skibicka, K. P., & Grill, H. J. (2009). Hindbrain leptin stimulation induces anorexia and hyperthermia mediated by hindbrain melanocortin receptors. Endocrinology, 1705–1711. https://doi.org/10.1210/en.2008-1316.
Small, C. J., Liu, Y. L., Stanley, S. A., Connoley, I. P., Kennedy, A., Stock, M. J., & Bloom, S. R. (2003). Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity, 530–533. https://doi.org/10.1038/sj.ijo.0802253.
Sobrino Crespo, C., Perianes Cachero, A., Puebla Jimenez, L., Barrios, V., & Arilla Ferreiro, E. (2014). Peptides and food intake. Frontiers in Endocrinology, 58. https://doi.org/10.3389/fendo.2014.00058.
Sohn, J. W., Elmquist, J. K., & Williams, K. W. (2013). Neuronal circuits that regulate feeding behavior and metabolism. Trends in Neurosciences, 504–512. https://doi.org/10.1016/j.tins.2013.05.003.
Solomon, S. (1999). POMC-derived peptides and their biological action. Annals of the New York Academy of Sciences, 885, 22–40.
Sominsky, L., & Spencer, S. J. (2014). Eating behavior and stress: A pathway to obesity. Frontiers in Psychology, 434. https://doi.org/10.3389/fpsyg.2014.00434.
Spencer, S. J., & Tilbrook, A. (2011). The glucocorticoid contribution to obesity. Stress, 233–246. https://doi.org/10.3109/10253890.2010.534831.
Stanley, B. G., Kyrkouli, S. E., Lampert, S., & Leibowitz, S. F. (1986). Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides, 7, 1189–1192.
Ste Marie, L., Luquet, S., Curtis, W., & Palmiter, R. D. (2005). Norepinephrine- and epinephrine-deficient mice gain weight normally on a high-fat diet. Obesity Research, 1518–1522. https://doi.org/10.1038/oby.2005.185.
Stephens, T. W., Basinski, M., Bristow, P. K., Bue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Kriauciunas, A., et al. (1995). The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530–532.
Stuber, G. D., & Wise, R. A. (2016). Lateral hypothalamic circuits for feeding and reward. Nature Neuroscience, 198–205. https://doi.org/10.1038/nn.4220.
Swanson, L. W., & Sawchenko, P. E. (1980). Paraventricular nucleus: A site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology, 31, 410–417.
Swanson, L. W., Sawchenko, P. E., Wiegand, S. J., & Price, J. L. (1980). Separate neurons in the paraventricular nucleus project to the median eminence and to the medulla or spinal cord. Brain Research, 198, 190–195.
Tataranni, P. A., Larson, D. E., Snitker, S., Young, J. B., Flatt, J. P., & Ravussin, E. (1996). Effects of glucocorticoids on energy metabolism and food intake in humans. The American Journal of Physiology, 271, E317–E325.
Thornton, J. E., Cheung, C. C., Clifton, D. K., & Steiner, R. A. (1997). Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology, 138, 5063–5066.
Tolle, V., & Low, M. J. (2008). In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice. Diabetes, 86–94. https://doi.org/10.2337/db07-0733.
Toorie, A. M., & Nillni, E. A. (2014). Minireview: Central Sirt1 regulates energy balance via the melanocortin system and alternate pathways. Molecular Endocrinology, 1423–1434. https://doi.org/10.1210/me.2014-1115.
Toorie, A. M., Cyr, N. E., Steger, J. S., Beckman, R., Farah, G., & Nillni, E. A. (2016). The nutrient and energy sensor Sirt1 regulates the hypothalamic-pituitary-adrenal (HPA) axis by altering the production of the prohormone convertase 2 (PC2) essential in the maturation of corticotropin releasing hormone (CRH) from its prohormone in male rats. The Journal of Biological Chemistry. https://doi.org/10.1074/jbc.M115.675264.
Toriya, M., Maekawa, F., Maejima, Y., Onaka, T., Fujiwara, K., Nakagawa, T., Nakata, M., & Yada, T. (2010). Long-term infusion of brain-derived neurotrophic factor reduces food intake and body weight via a corticotrophin-releasing hormone pathway in the paraventricular nucleus of the hypothalamus. Journal of Neuroendocrinology, 987–995. https://doi.org/10.1111/j.1365-2826.2010.02039.x.
Travagli, R. A., Hermann, G. E., Browning, K. N., & Rogers, R. C. (2006). Brainstem circuits regulating gastric function. Annual Review of Physiology, 279–305. https://doi.org/10.1146/annurev.physiol.68.040504.094635.
Trayhurn, P., Thurlby, P. L., & James, W. P. (1977). Thermogenic defect in pre-obese ob/ob mice. Nature, 266, 60–62.
Vaisse, C., Halaas, J. L., Horvath, C. M., Darnell, J. J. E., Stoffel, M., & Friedman, J. M. (1996). Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nature Genetics, 14, 95–97.
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 18;213(4514):1394–1397.
Veo, K., Reinick, C., Liang, L., Moser, E., Angleson, J. K., & Dores, R. M. (2011). Observations on the ligand selectivity of the melanocortin 2 receptor. General and Comparative Endocrinology, 3–9. https://doi.org/10.1016/j.ygcen.2011.04.006.
Whittle, A. J., & Vidal-Puig, A. (2012). NPs – heart hormones that regulate brown fat? The Journal of Clinical Investigation, 804–807. https://doi.org/10.1172/JCI62595.
Willesen, M. G., Kristensen, P., & Romer, J. (1999). Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology, 70, 306–316.
Williams, D. L., Kaplan, J. M., & Grill, H. J. (2000). The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology, 141, 1332–1337.
Wirth, M. M., PK Olszewski, C. Y., Levine, A. S., & Giraudo, S. Q. (2001). Paraventricular hypothalamic alpha-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects. Peptides, 22, 129–134.
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D., Jr. (1979). Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature, 282, 503–505.
Wu, Q., & Palmiter, R. D. (2011). GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism. European Journal of Pharmacology, 21–27. https://doi.org/10.1016/j.ejphar.2010.10.110.
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience, 736–742. https://doi.org/10.1038/nn1073.
Xu, A. W., Kaelin, C. B., Morton, G. J., Ogimoto, K., Stanhope, K., Graham, J., Baskin, D. G., Havel, P., Schwartz, M. W., & Barsh, G. S. (2005). Effects of hypothalamic neurodegeneration on energy balance. PLoS Biology, e415. https://doi.org/10.1371/journal.pbio.0030415.
Yaswen, L., Diehl, N., Brennan, M. B., & Hochgeschwender, U. (1999). Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nature Medicine, 1066–1070. https://doi.org/10.1038/12506.
Yeo, G. S., Connie Hung, C. C., Rochford, J., Keogh, J., Gray, J., Sivaramakrishnan, S., O'Rahilly, S., & Farooqi, I. S. (2004). A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience, 1187–1189. https://doi.org/10.1038/nn1336.
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425–432.
Zhang, R., Dhillon, H., Yin, H., Yoshimura, A., Lowell, B. B., Maratos-Flier, E., & Flier, J. S. (2008). Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology, 5654–5661. https://doi.org/10.1210/en.2008-0805.
Zhao, K., Ao, Y., Harper, R. M., Go, V. L., & Yang, H. (2013). Food-intake dysregulation in type 2 diabetic Goto-Kakizaki rats: Hypothesized role of dysfunctional brainstem thyrotropin-releasing hormone and impaired vagal output. Neuroscience, 43, 54. https://doi.org/10.1016/j.neuroscience.2013.05.017.
Zheng, H., Patterson, L. M., Phifer, C. B., & Berthoud, H. R. (2005). Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 289, R247–R258.
Zheng, H., Patterson, L. M., Rhodes, C. J., Louis, G. W., Skibicka, K. P., Grill, H. J., Myers, M. G., Jr., & Berthoud, H. R. (2010). A potential role for hypothalamomedullary POMC projections in leptin-induced suppression of food intake. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, R720–R728. https://doi.org/10.1152/ajpregu.00619.2009.
Ziegler, C. G., Krug, A. W., Zouboulis, C. C., & Bornstein, S. R. (2007). Corticotropin releasing hormone and its function in the skin. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 106–109. https://doi.org/10.1055/s-2007-961809.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Nillni, E.A. (2018). Neuropeptides Controlling Our Behavior. In: Nillni, E. (eds) Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function. Springer, Cham. https://doi.org/10.1007/978-3-319-89506-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-89506-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89505-5
Online ISBN: 978-3-319-89506-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)